Ocugen (NASDAQ:OCGN) Stock Falls 50% YTD: What Next?

May 23, 2022

The possibility of marketing the coronavirus vaccine Covaxin had been one of the major triggers behind the remarkable rally that was seen in the Ocugen (NASDAQ:OCGN) stock from back in December 2020 up until November 2021. However, things have fallen apart for the company throughout the past few months. Trading Data On Friday, OCGN stock fell 0.45% to $2.23 with more than 5.20 million shares, compared to its average volume…


Ocugen Inc (NASDAQ:OCGN) Stock Falls As FDA places Clinical Hold

April 13, 2022

The slide in the Ocugen Inc (NASDAQ:OCGN) stock continued on Tuesday as the selloff carried on and it ended the day with a decline of 4%. That took the cumulative decline in the stock over the course of the past week to as much as 14%. Trading Data On Tuesday, OCGN stock moved down 3.80% to $2.79 with 10.28 million shares, compared to its average volume of 12.08 million shares….


Ocugen Inc (NASDAQ:OCGN) Stock Gains 30% In a Week On Short Squeeze

March 24, 2022

In the past week, the Ocugen Inc (NASDAQ:OCGN) stock has emerged as one to watch loosely in light of the fact that it clocked gains of as much as 30% during the period. Trading Data On Wednesday, OCGN stock fell 4.43% to $3.67 with more than 9.43 million shares, compared to its average volume of 13.32 million shares. The stock moved within a range of $3.6500 – 3.9800 after opening…